BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37697722)

  • 1. Computational evaluation of phytochemicals targeting DNA topoisomerase I in
    Arya PK; Mandal P; Barik K; Singh DV; Kumar A
    J Biomol Struct Dyn; 2023 Sep; ():1-14. PubMed ID: 37697722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
    Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
    J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
    [No Abstract]   [Full Text] [Related]  

  • 3. In-silico studies on Myo inositol-1-phosphate synthase of
    Sinha M; Jagadeesan R; Kumar N; Saha S; Kothandan G; Kumar D
    J Biomol Struct Dyn; 2022 May; 40(8):3371-3384. PubMed ID: 33200690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from
    Wadanambi PM; Mannapperuma U
    Heliyon; 2021 Jun; 7(6):e07178. PubMed ID: 34141935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing based novel anti-leishmanial drug screening using
    Rai P; Arya H; Saha S; Kumar D; Bhatt TK
    J Biomol Struct Dyn; 2022; 40(21):10812-10820. PubMed ID: 36529188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 7. Computational multi-target approach to target essential enzymes of Leishmania donovani using comparative molecular dynamic simulations and MMPBSA analysis.
    Saha D; Nath Jha A
    Phytochem Anal; 2023 Oct; 34(7):842-854. PubMed ID: 36760044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study.
    Saha S; Sharma A; Bhowmik D; Kumar D
    Mol Divers; 2024 May; ():. PubMed ID: 38722455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of potential inhibitors of
    Tewari D; Rawat K; Bisht A; Almoyad MAA; Wahab S; Chandra S; Pande V
    J Biomol Struct Dyn; 2023 Nov; ():1-18. PubMed ID: 37922151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
    Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
    Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug designing against
    Sarma M; Borkotoky S; Dubey VK
    J Biomol Struct Dyn; 2023 Jul; ():1-9. PubMed ID: 37491862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
    Azeem M; Mustafa G; Mahrosh HS
    Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential anti-leishmanial agents using computational investigation and biological evaluation against trypanothione reductase.
    Kuldeep J; R K; Kaur P; Goyal N; Siddiqi MI
    J Biomol Struct Dyn; 2021 Feb; 39(3):960-969. PubMed ID: 31984862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
    Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
    Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential novel inhibitors against glutamine synthetase enzyme of Leishmania major by using computational tools.
    Kashif M; Subbarao N
    J Biomol Struct Dyn; 2023; 41(23):13914-13922. PubMed ID: 36744549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
    Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A
    Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the inhibitory potential of Valproic acid against histone deacetylase of
    Prasanna P; Joshi T; Pant M; Pundir H; Chandra S
    J Biomol Struct Dyn; 2023; 41(12):5447-5464. PubMed ID: 35706132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.